Integrating Flower Essences Therapy and Intuition into a Holistic Life Coaching Practice

2017 ◽  
Vol 1 (1) ◽  
pp. 2-9
Author(s):  
Dr Alicia Holland
Keyword(s):  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Jette Ammentorp ◽  
Lisbeth Uhrenfeldt ◽  
Flemming Angel ◽  
Martin Ehrensvärd ◽  
Ebbe B Carlsen ◽  
...  

2009 ◽  
pp. 103-106
Author(s):  
Eugenia Laria ◽  
Franco Rosu ◽  
Massimo Fancellu
Keyword(s):  

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e24103-e24103
Author(s):  
Rahul Banerjee ◽  
Chiung-Yu Huang ◽  
Lisa Dunn ◽  
Jennifer Knoche ◽  
Kelly Jean Brassil ◽  
...  

e24103 Background: Patients with multiple myeloma (MM) experience acute quality of life (QOL) exacerbations following autologous stem cell transplantation (ASCT) that can lead to long-term complications. Life coaching can improve QOL in a structured & personalized manner. We investigated the feasibility of a digital life coaching (DLC) platform, where coaching is accomplished through phone calls and text messages, for patients with MM during ASCT. Methods: Our pilot study (clinicaltrials.gov ID: NCT04432818) enrolled adult patients with MM, English proficiency, and cellphone ownership (smartphone not required). The 16-week DLC program, beginning at Day -5 before ASCT, included unlimited digital access to a certified life coach to help with identifying and accomplishing wellness-related goals. Our primary outcome was ongoing DLC engagement (≥ 1 bidirectional conversation every 4 weeks). Secondary outcomes were ePRO assessments of QOL (PROMIS Global Health), insomnia (PROMIS Sleep Disturbances), and distress (NCCN DT). Electronic patient-reported outcome (ePRO) assessments were delivered via automated REDCap emails every 1-2 weeks. Results: Of 18 screened patients, 15 (83%) enrolled in our study; 2 patients dropped out before initiating DLC (including 1 who was unable to connect with her coach between Day -5 and 0). Of 13 remaining patients, median age was 65 (range 50-81) and 23% had an ECOG performance status of 1 (remainder 0). DLC conversations occurred a mean of every 7.6 days (range 3-28) overall and every 6.5 days (range 2.8-14) during the initial 28-day period including high-dose melphalan and hospitalization. 80% of patients maintained ≥ 1 conversation every 4 weeks. Selected ePRO results (mean ± standard error) are shown in the table. Conclusions: Certain MM patients are able to engage digitally with a life coach and complete email-based ePRO assessments during and after ASCT. Limitations of our study include selection bias and the Day -5 start date, which may be too late logistically and symptom-wise (given our ePRO findings suggestive of peak distress pre-ASCT). DLC may play an innovative and scalable role given the emphasis on remotely delivered care during the COVID-19 pandemic. A Phase II randomized study of DLC versus usual care is under way (clinicaltrials.gov ID: NCT04589286). Clinical trial information: NCT04432818. [Table: see text]


2015 ◽  
pp. 101-144
Author(s):  
Uwe Böning ◽  
Claudia Kegel
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document